FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

1103661000000108: Radioligand therapy using lutetium (177-Lu) labeled somatostatin analog (procedure)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Oct 2024. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
5144458014 A targeted cancer treatment that delivers radiation to select types of cells using a radioligand. A radioligand has two components, a radioisotope, in this case, lutetium (177-Lu) labeled somatostatin analog and a cell-targeting compound known as a ligand. en Definition Active Entire term case sensitive (core metadata concept) SNOMED CT core
5144461010 A targeted cancer treatment that delivers radiation to select types of cells using a radioligand. A radioligand has two components, a radioisotope, in this case, lutetium (177-Lu) labelled somatostatin analogue and a cell-targeting compound known as a ligand. en Definition Active Entire term case sensitive (core metadata concept) SNOMED CT core
5144450019 Radioligand therapy using lutetium (177-Lu) labeled somatostatin analog (procedure) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
5144451015 Radioligand therapy using lutetium (177-Lu) labeled somatostatin analog en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
5144452010 Radioligand therapy using lutetium (177-Lu) labelled somatostatin analogue en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
5144453017 Lutetium (177-Lu) labeled somatostatin analog therapy en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
5144454011 Lutetium (177-Lu) labelled somatostatin analogue therapy en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
A targeted cancer treatment that delivers radiation to select types of cells using a radioligand. A radioligand has two components, a radioisotope, in this case, lutetium (177-Lu) labeled somatostatin analog and a cell-targeting compound known as a ligand. Is a Radionuclide therapy false Inferred relationship Some
A targeted cancer treatment that delivers radiation to select types of cells using a radioligand. A radioligand has two components, a radioisotope, in this case, lutetium (177-Lu) labeled somatostatin analog and a cell-targeting compound known as a ligand. Method Radioactive destruction false Inferred relationship Some 1
A targeted cancer treatment that delivers radiation to select types of cells using a radioligand. A radioligand has two components, a radioisotope, in this case, lutetium (177-Lu) labeled somatostatin analog and a cell-targeting compound known as a ligand. Using substance (attribute) Lutetium (177-Lu) labeled somatostatin analog false Inferred relationship Some 1
A targeted cancer treatment that delivers radiation to select types of cells using a radioligand. A radioligand has two components, a radioisotope, in this case, lutetium (177-Lu) labeled somatostatin analog and a cell-targeting compound known as a ligand. Has intent Therapeutic false Inferred relationship Some 2
A targeted cancer treatment that delivers radiation to select types of cells using a radioligand. A radioligand has two components, a radioisotope, in this case, lutetium (177-Lu) labeled somatostatin analog and a cell-targeting compound known as a ligand. Using energy (attribute) Radiation false Inferred relationship Some 2
A targeted cancer treatment that delivers radiation to select types of cells using a radioligand. A radioligand has two components, a radioisotope, in this case, lutetium (177-Lu) labeled somatostatin analog and a cell-targeting compound known as a ligand. Is a Radiotherapy false Inferred relationship Some
A targeted cancer treatment that delivers radiation to select types of cells using a radioligand. A radioligand has two components, a radioisotope, in this case, lutetium (177-Lu) labeled somatostatin analog and a cell-targeting compound known as a ligand. Using energy (attribute) Radiation false Inferred relationship Some 3
A targeted cancer treatment that delivers radiation to select types of cells using a radioligand. A radioligand has two components, a radioisotope, in this case, lutetium (177-Lu) labeled somatostatin analog and a cell-targeting compound known as a ligand. Method Administration - action false Inferred relationship Some 3
A targeted cancer treatment that delivers radiation to select types of cells using a radioligand. A radioligand has two components, a radioisotope, in this case, lutetium (177-Lu) labeled somatostatin analog and a cell-targeting compound known as a ligand. Is a Targeted radionuclide therapy (procedure) true Inferred relationship Some
A targeted cancer treatment that delivers radiation to select types of cells using a radioligand. A radioligand has two components, a radioisotope, in this case, lutetium (177-Lu) labeled somatostatin analog and a cell-targeting compound known as a ligand. Is a Administration of hormone true Inferred relationship Some
A targeted cancer treatment that delivers radiation to select types of cells using a radioligand. A radioligand has two components, a radioisotope, in this case, lutetium (177-Lu) labeled somatostatin analog and a cell-targeting compound known as a ligand. Method Administration - action true Inferred relationship Some 1
A targeted cancer treatment that delivers radiation to select types of cells using a radioligand. A radioligand has two components, a radioisotope, in this case, lutetium (177-Lu) labeled somatostatin analog and a cell-targeting compound known as a ligand. Direct substance Lutetium (177-Lu) labeled somatostatin analog true Inferred relationship Some 1
A targeted cancer treatment that delivers radiation to select types of cells using a radioligand. A radioligand has two components, a radioisotope, in this case, lutetium (177-Lu) labeled somatostatin analog and a cell-targeting compound known as a ligand. Method Administration - action true Inferred relationship Some 2
A targeted cancer treatment that delivers radiation to select types of cells using a radioligand. A radioligand has two components, a radioisotope, in this case, lutetium (177-Lu) labeled somatostatin analog and a cell-targeting compound known as a ligand. Using energy (attribute) Ionizing radiation true Inferred relationship Some 2
A targeted cancer treatment that delivers radiation to select types of cells using a radioligand. A radioligand has two components, a radioisotope, in this case, lutetium (177-Lu) labeled somatostatin analog and a cell-targeting compound known as a ligand. Using substance (attribute) Lutetium (177-Lu) labeled somatostatin analog true Inferred relationship Some 2
A targeted cancer treatment that delivers radiation to select types of cells using a radioligand. A radioligand has two components, a radioisotope, in this case, lutetium (177-Lu) labeled somatostatin analog and a cell-targeting compound known as a ligand. Is a Nuclear medicine procedure (procedure) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start